27 Scientific Studies Relative To Protein and Glucose -- Diabetes

       

Search Results
Results for your query on September 23, 2000:
Words in title only: protein metabolism And glucose
Published in 1955 through 1999
Only select references with abstracts available
Show references published in English only
Show references pertaining to humans

Documents: 1 to 27 of 27

1

Top Of Menu

Hoffer LJ, et al; Dietary protein restriction alters glucose but not protein metabolism in non-insulin-dependent diabetes mellitus. (Metabolism, 1998 Sep, Abstract available) [MEDLINE]

2 Andersén E, et al; Effects of a high-protein and low-fat diet vs a low-protein and high-fat diet on blood glucose, serum lipoproteins, and cholesterol metabolism in noninsulin-dependent diabetics. (Am J Clin Nutr, 1987 Feb, Abstract available) [MEDLINE]
3 Solini A, et al; Protein metabolism in human obesity: relationship with glucose and lipid metabolism and with visceral adipose tissue. (J Clin Endocrinol Metab, 1997 Aug, Abstract available) [MEDLINE]
4 Shaw JH, et al; Metabolic intervention in surgical patients: the effect of alpha- or beta-blockade on glucose and protein metabolism in surgical patients receiving total parenteral nutrition. (Surgery, 1988 May, Abstract available) [MEDLINE]
5 Shaw JH, et al; An integrated analysis of glucose, fat, and protein metabolism in severely traumatized patients. Studies in the basal state and the response to total parenteral nutrition. (Ann Surg, 1989 Jan, Abstract available) [MEDLINE]
6 Linn T, et al; Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependent diabetes mellitus. (J Clin Endocrinol Metab, 1996 Nov, Abstract available) [MEDLINE]
7 Zillikens MC, et al; Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls. (J Hepatol, 1993 Mar, Abstract available) [MEDLINE]
8 Long CL, et al; Glutamine supplementation of enteral nutrition: impact on whole body protein kinetics and glucose metabolism in critically ill patients. (JPEN J Parenter Enteral Nutr, 1995 Nov, Abstract available) [MEDLINE]
9 Fryburg DA, et al; Effects of epinephrine on human muscle glucose and protein metabolism. (Am J Physiol, 1995 Jan, Abstract available) [MEDLINE]
10

Menu Position #10

Shepherd PR, et al; Involvement of phosphoinositide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: implications for glucose metabolism. (Diabetologia, 1997 Oct, Abstract available) [MEDLINE]

11 Hill MW, et al; Glucose metabolism and protein synthesis in stratified squamous epithelia from young and old mice. (Exp Gerontol, 1989, Abstract available) [MEDLINE]
12 Gore DC, et al; Except for alanine, muscle protein catabolism is not influenced by alterations in glucose metabolism during sepsis. (Arch Surg, 1995 Nov, Abstract available) [MEDLINE]
13 Flakoll PJ, et al; Protein and glucose metabolism during isolated closed-head injury. (Am J Physiol, 1995 Oct, Abstract available) [MEDLINE]
14 Newman E, et al; The effect of insulin on glucose and protein metabolism in the forearm of cancer patients. (Surg Oncol, 1992 Aug, Abstract available) [MEDLINE]
15 Passilta M, et al; Glucose metabolism, insulin-like growth factor-I, and insulin-like growth factor-binding protein-1 after alcohol withdrawal. (Alcohol Clin Exp Res, 1999 Mar, Abstract available) [MEDLINE]
16 Battezzati A, et al; Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma. (Diabetes, 1995 Jul, Abstract available) [MEDLINE]
17 Louard RJ, et al; Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle. (J Clin Invest, 1992 Dec, Abstract available) [MEDLINE]
18 Bresson JL, et al; Protein-metabolism kinetics and energy-substrate utilization in infants fed parenteral solutions with different glucose-fat ratios [see comments] (Am J Clin Nutr, 1991 Aug, Abstract available) [MEDLINE]
19 Larivière F, et al; Effects of dietary protein restriction on glucose and insulin metabolism in normal and diabetic humans. (Metabolism, 1994 Apr, Abstract available) [MEDLINE]
20

Menu Position #20

Franz MJ; Protein: metabolism and effect on blood glucose levels. (Diabetes Educ, 1997 Nov, Abstract available) [MEDLINE]

21 Mak RH, et al; The effect of a low protein diet with amino acid/keto acid supplements on glucose metabolism in children with uremia. (J Clin Endocrinol Metab, 1986 Oct, Abstract available) [MEDLINE]
22 Arslanian S, et al; Testosterone treatment in adolescents with delayed puberty: changes in body composition, protein, fat, and glucose metabolism. (J Clin Endocrinol Metab, 1997 Oct, Abstract available) [MEDLINE]
23 Castellino P, et al; Dissociation of the effects of epinephrine and insulin on glucose and protein metabolism. (Am J Physiol, 1990 Jan, Abstract available) [MEDLINE]
24 Dietz WH Jr, et al; Interrelationships of glucose and protein metabolism in obese adolescents during short-term hypocaloric dietary therapy. (Am J Clin Nutr, 1985 Sep, Abstract available) [MEDLINE]
25 Roy BD, et al; Effect of glucose supplement timing on protein metabolism after resistance training. (J Appl Physiol, 1997 Jun, Abstract available) [MEDLINE]
26 Zillikens MC, et al; Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls. (J Hepatol, 1993 Mar, Abstract available) [MEDLINE]
27 Rigalleau V, et al; Low protein diet in uremia: effects on glucose metabolism and energy production rate. (Kidney Int, 1997 Apr, Abstract available) [MEDLINE]


GTO  

Information on HealthGate.com is not a substitute for professional medical care or advice but should be used only as an aid in understanding current medical knowledge. A physician should always be consulted for any health problem or medical condition.

We subscribe to the HONcode principles
of the Health On the Net Foundation

Send comments to support@healthgate.com
Copyright © 2000 HealthGate® Data Corp. All rights reserved.

Record 1 from database: MEDLINE
Return To Top

Title
Dietary protein restriction alters glucose but not protein metabolism in non-insulin-dependent diabetes mellitus.
Author
Hoffer LJ; Taveroff A; Hamadeh MJ
Address
McGill Nutrition and Food Science Centre and the School of Dietetics and Human Nutrition, McGill University, Montreal, Quebec, Canada.
Source
Metabolism, 1998 Sep, 47:9, 1145-51
Abstract
We determined whether a customary diet high or low in protein (1) influences postabsorptive amino acid catabolism, nitrogen (N) balance, and hepatic glucose output (HGO) in normal subjects or patients with non-insulin-dependent diabetes mellitus (NIDDM) or (2) alters blood glucose levels in NIDDM. Eight normal young adults and five obese middle-aged persons with NIDDM consumed low-protein (0.8 g/kg lean body mass [LBM]) or high-protein (3.0 g/kg LBM) diets at maintenance energy for consecutive 7-day periods. Fasting and average blood glucose and N balance were measured daily. The level of dietary protein had no effect on the basal plasma leucine rate of appearance (Ra) or urinary 3-methylhistidine excretion in either subject group. Basal leucine oxidation (and by inference, whole-body amino acid catabolism) was reduced on the low-protein diet but basal HGO was not, and although exogenous glucose effectively suppressed HGO, it did not reduce leucine oxidation with either diet. After adaptation to the low-protein diet, N balance in both the normal and NIDDM subjects was close to zero. The low-protein diet reduced the fasting and daily blood glucose of the diabetic subjects by approximately 2 mmol/L (P < .05). We conclude that physiologic variation in dietary protein does not affect basal whole-body protein turnover or HGO in either normal young adults or obese middle-aged NIDDM subjects. However, protein restriction to the level of the average daily requirement significantly reduces postabsorptive and average daily blood glucose concentrations in persons with NIDDM.
Language of Publication
English
Unique Identifier
98421866

Return To Top


MeSH Heading (Major)
Diabetes Mellitus, Non-Insulin-Dependent|*ME; Dietary Proteins|*AD; Glucose|*ME; Proteins|*ME
MeSH Heading
Adult; Body Weight; Female; Human; Liver|ME; Male; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0026-0495
Country of Publication
UNITED STATES

Record 2 from database: MEDLINE
Return To Top

Title
Effects of a high-protein and low-fat diet vs a low-protein and high-fat diet on blood glucose, serum lipoproteins, and cholesterol metabolism in noninsulin-dependent diabetics.
Author
Andersén E; Hellström P; Kindstedt K; Hellström K
Address
 
Source
Am J Clin Nutr, 1987 Feb, 45:2, 406-13
Abstract
Six middle-aged patients with noninsulin-dependent diabetes and six normoglycemic control subjects were fed protein-rich and fat-poor (diet A) or protein-poor and fat-rich food (diet B). The patients were hyperglycemic, VLDL triglycerides levels were higher, and HDL cholesterol levels lower than corresponding findings in control subjects. Bile acid formation and biliary lipid composition did not differ between the two groups, but net steroid balance in the patients was elevated by a factor of approximately 2. A switch from diet A to diet B in control subjects was associated with an increase in HDL cholesterol and decreases in bile acid synthesis and net steroid balance. Lipoprotein pattern in the patients remained unchanged, and effects on total bile acid production and steroid balance were less consistent. It is suggested that the response in the patients reflected diabetes-associated abnormalities in lipid metabolism.
Language of Publication
English
Unique Identifier
87124596

Return To Top


MeSH Heading (Major)
Diabetes Mellitus, Non-Insulin-Dependent|BL/CO/*DH; Diabetic Diet|*; Dietary Fats|*AD; Dietary Proteins|*AD; Hyperlipoproteinemia|*DH/ET
MeSH Heading
Adult; Aged; Blood Glucose|ME; Cholesterol|ME; Comparative Study; Female; Human; Lipoproteins|BL; Male; Middle Age; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0002-9165
Country of Publication
UNITED STATES

Record 3 from database: MEDLINE
Return To Top

Title
Protein metabolism in human obesity: relationship with glucose and lipid metabolism and with visceral adipose tissue.
Author
Solini A; Bonora E; Bonadonna R; Castellino P; DeFronzo RA
Address
Department of Internal Medicine, University of Ferrara, Italy.
Source
J Clin Endocrinol Metab, 1997 Aug, 82:8, 2552-8
Abstract
It is controversial whether metabolic disorders of human obesity include protein metabolism. Even less information is available concerning the effect of fat distribution on protein metabolism. Therefore, a comprehensive evaluation of glucose, lipid, and protein metabolism was performed in 11 obese nondiabetic and 9 normal women whose body composition and regional fat distribution were determined. [1-14C]Leucine and [3-3H]glucose were infused in the postabsorptive state and during an euglycemic hyperinsulinemic (35-40 microU/mL) clamp combined with indirect calorimetry for assessment of leucine flux, oxidation, and nonoxidative disposal, glucose turnover and oxidation, and lipid oxidation. Fat-free mass (FFM) was estimated by a bolus of 3H2O. Subcutaneous abdominal and visceral adipose tissues were determined by nuclear magnetic resonance imaging. During the clamp, obese women had lower glucose turnover (4.51 +/- 0.41 vs. 6.63 +/- 0.40 mg/min.kg FFM; P < 0.05), with a defect in both oxidation (3.27 +/- 0.22 vs. 3.89 +/- 0.21) and nonoxidative disposal (1.24 +/- 0.27 vs. 2.74 +/- 0.41; P < 0.005), whereas lipid oxidation was higher during the clamp (0.49 +/- 0.15 vs. 0.17 +/- 0.09 mg/min.kg FFM). There was no difference in leucine flux (basal, 2.23 +/- 0.17 vs. 2.30 +/- 0.29; clamp, 2.06 +/- 0.19 vs. 2.10 +/- 0.24 mumol/min.kg FFM), oxidation (basal, 0.37 +/- 0.04 vs. 0.36 +/- 0.05; clamp, 0.34 +/- 0.04 vs. 0.39 +/- 0.06) and nonoxidative leucine disposal (basal, 1.86 +/- 0.17 vs. 1.94 +/- 0.26; clamp, 1.72 +/- 0.20 vs. 1.71 +/- 0.19) in the two groups. In obese women, basal leucine oxidation was directly related with glucose oxidation and inversely to lipid oxidation (both P < 0.05), whereas visceral adipose tissue was inversely related to leucine flux both in the basal state and during the clamp (P < 0.05). In conclusion, in human obesity, 1) rates of protein metabolism in the basal state and in the range of insulin concentrations encountered after a meal are normal; 2) protein oxidation is positively related to glucose oxidation and negatively related to lipid oxidation; and 3) visceral adipose tissue is inversely related to all parameters of protein metabolism.
Language of Publication
English
Unique Identifier
97397272

Return To Top


MeSH Heading (Major)
Blood Glucose|*ME; Lipids|*BL; Obesity|*ME; Proteins|*ME
MeSH Heading
Adipose Tissue; Adult; Body Composition; Calorimetry, Indirect; Fatty Acids, Nonesterified|BL; Female; Food; Glucose|ME; Glucose Clamp Technique; Human; Insulin|BL; Leucine|ME; Lipid Peroxidation; Oxidation-Reduction; Support, Non-U.S. Gov't; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0021-972X
Country of Publication
UNITED STATES

Record 4 from database: MEDLINE
Return To Top

Title
Metabolic intervention in surgical patients: the effect of alpha- or beta-blockade on glucose and protein metabolism in surgical patients receiving total parenteral nutrition.
Author
Shaw JH; Holdaway CM; Humberstone DA
Address
University Department of Surgery, Auckland Hospital, New Zealand.
Source
Surgery, 1988 May, 103:5, 520-5
Abstract
We performed a series of isotopic studies on the role of alpha- or beta-adrenergic activity in the regulation of glucose and protein metabolism in a group of surgical patients receiving total parenteral nutrition. We quantitated rates of glucose turnover and net protein breakdown by the primed constant infusion of 3H-glucose and 14C-urea, respectively. Basal measurements were first performed, and then the effect of either alpha- or beta-adrenergic blockade was assessed by means of the constant infusion of either phentolamine or propranolol. In addition, we assessed the effect of beta-stimulation by infusing the beta-agonist, salbutamol. The institution of alpha-adrenergic blockade did not significantly alter either the plasma glucose level or the rate of glucose production. However, the rate of net protein catabolism decreased significantly after alpha-adrenergic blockade. Before alpha-blockade the value for NPC was 0.88 +/- 0.27 gm/kg/day, and after alpha-blockade the corresponding value was 0.73 +/- 0.24 gm/kg/day (p less than 0.01). beta-Adrenergic blockade resulted in a decrease in the rate of glucose appearance from 38.2 +/- 6.1 mumol/kg/min to 35.1 +/- 5.7 mumol/kg/min, and the plasma glucose clearance increased from 5.0 +/- 0.8 ml/kg/min to 5.4 +/- 0.8 ml/kg/min. As a result of these changes the plasma glucose concentration decreased significantly (p less than 0.01) from 7.4 +/- 0.3 mumol/ml to 6.5 +/- 0.5 mumol/ml. beta-Adrenergic blockade did not significantly decrease the rate of net protein catabolism. beta-Stimulation with salbutamol resulted in a significant increase (p less than 0.05) in the rate of glucose production from 31.3 +/- 4.2 mumol/kg/min to 38.0 +/- 6.5 mumol/kg/min, and as a result the plasma glucose level increased significantly from 6.7 +/- 0.6 mumol/ml to 7.4 +/- 0.6 mumol/ml (p less than 0.04). We conclude from these studies that the role of the adrenergic nervous system in the promotion of endogenous glucose turnover in surgical patients receiving total parenteral nutrition is primarily a beta-adrenergic effect, whereas the promotion of protein catabolism is mainly an alpha-adrenergic effect.
Language of Publication
English
Unique Identifier
88205181

Return To Top


MeSH Heading (Major)
Adrenergic alpha-Antagonists|AD/*PD; Adrenergic beta-Antagonists|AD/*PD; Energy Metabolism|*; Glucose|*ME; Parenteral Nutrition, Total|*; Proteins|*ME; Surgical Procedures, Operative|*
MeSH Heading
Adult; Aged; Albuterol|AD/PD; Blood Glucose|AN; Female; Human; Hydrocortisone|BL; Infusions, Intravenous; Insulin|BL; Male; Middle Age; Support, Non-U.S. Gov't; Urea|UR

Publication Type
JOURNAL ARTICLE
ISSN
0039-6060
Country of Publication
UNITED STATES

Record 5 from database: MEDLINE
Return To Top

Title
An integrated analysis of glucose, fat, and protein metabolism in severely traumatized patients. Studies in the basal state and the response to total parenteral nutrition.
Author
Shaw JH; Wolfe RR
Address
University Department of Surgery, Auckland Hospital, New Zealand.
Source
Ann Surg, 1989 Jan, 209:1, 63-72
Abstract
A series of isotopic infusions were performed in 43 severely ill patients suffering from blunt trauma (mean injury severity score of 31). The patient data have been compared with data obtained from 32 normal volunteers, and in addition the metabolic response of the trauma patient to total nutritional support (TPN) has been assessed. The rate of VO2 was elevated in the trauma patients compared with that of the volunteers (160 mumol/kg/minute vs. 103 mumol/kg/minute). Glucose production was significantly increased in the patients compared with the volunteers (21 +/- 2 mumol/kg/minute vs. 14 +/- 1 mumol/kg/minute), but the trauma patients had an impaired capacity to directly oxidize plasma glucose. The percentage of glucose uptake oxidized in the volunteers was 36 +/- 2%, and the percentage of glucose uptake recycled was 10 +/- 1%. By contrast, in the trauma patients, 23 +/- 4% of the glucose uptake was directly oxidized, and 29 +/- 11% was recycled. The rate of glycerol turnover in the trauma patients (5.3 +/- 0.3 mumol/kg/minute) was significantly elevated compared with the volunteer value (2.2 +/- 0.1 mumol/kg/minute), and the basal rate of fat oxidation was twice as high in the patients as in the volunteers (2 mg/kg/minute vs. 1 mg/kg/minute). The rate of whole body protein catabolism was significantly higher in the patients (5.8 +/- 0.7 g/kg/day vs. 4.3 +/- 0.3 g/kg/day), and as a result, the rate of net protein catabolism was significantly elevated in the patients. The response to TPN (amino acids and a 50:50 mixture of glucose and fat) included an increase in the percentage of glucose uptake oxidized (up to 45 +/- 12%), a decrease in the oxidation of fat (up to 0.8 mg/kg/minute), and a significant increase in whole body protein synthesis (up to 6.1 +/- 1.1 g/kg/day) so that the rate of net protein loss was minimized but not prevented. (The rate of net protein catabolism during TPN was 1.3 +/- 0.5 g/kg/day.) There was no correlation between the injury severity score (ISS) and the degree of metabolic abnormality. The rate of NPC in the patients with ISS less than 20 was higher than in the volunteers (ISS = 0), but the values for NPC in patients with ISS 21-40, and ISS greater than 40 were virtually identical to the corresponding values in patients with ISS less than 20. It is concluded from these studies that: 1) Trauma patients have a high rate of VO2.(ABSTRACT TRUNCATED AT 250 WORDS)
Language of Publication
English
Unique Identifier
89087212

Return To Top


MeSH Heading (Major)
Basal Metabolism|*; Fats|*ME; Glucose|*ME; Parenteral Nutrition, Total|*; Proteins|*ME; Wounds, Nonpenetrating|*ME/TH
MeSH Heading
Adolescence; Adult; Calorimetry; Energy Intake; Evaluation Studies; Fatty Acids, Nonesterified|ME; Female; Human; Hydrocortisone|BL; Insulin|BL; Kinetics; Male; Middle Age; Oxidation-Reduction; Oxygen Consumption; Severity of Illness Index; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0003-4932
Country of Publication
UNITED STATES

Record 6 from database: MEDLINE
Return To Top

Title
Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependent diabetes mellitus.
Author
Linn T; Geyer R; Prassek S; Laube H
Address
Diabetology and Metabolism Unit, Justus Liebig University, Giessen, Germany.
Source
J Clin Endocrinol Metab, 1996 Nov, 81:11, 3938-43
Abstract
Adult-onset insulin dependent diabetes mellitus (IDDM) is associated with significant residual insulin secretion. The process leading to the ultimate destruction of B cells may be influenced, among other factors, by the quality and amount of ingested protein. Using a standardized food questionnaire, we matched 13 individuals with normal protein (NP; 0.74 +/- 0.08 g/kg.day) and high protein (HP; 1.87 +/- 0.26 g/kg.day) intake from a sample of 117 newly diagnosed IDDM patients according to sex, age, body mass index, and energy intake. Nondiabetic control subjects were also selected. Dietary habits did not change significantly over an observation period of 1 yr. Glucagon-stimulated C peptide was significantly higher in the NP compared to the HP group (0.71 +/- 0.06 vs. 0.50 +/- 0.04 nmol/L; P < 0.002). NP food was associated with higher overall insulin sensitivity in both patients and nondiabetic subjects. Hepatic glucose output was significantly increased in individuals with HP intake [HP IDDM, 14.8 +/- 0.6 vs. NP IDDM, 12.7 +/- 0.7 (P < 0.01); HP control, 12.2 +/- 0.5 vs. NP control, 10.9 +/- 0.5 (P < 0.01 mumol/kg.min). Insulin-mediated suppression of hepatic glucose production was impaired in diabetic patients with high protein intake, but not in patients with normal protein diet. Gluconeogenesis estimated from 13C enrichment in breath and plasma was increased in individuals on a HP diet. We conclude that a NP diet is accompanied by delayed progression of the continuous loss of endogenous insulin in IDDM. This phenomenon is possibly due to decreased insulin demand on the B cells and/or reduced hepatic glucose production favoring enhanced insulin sensitivity.
Language of Publication
English
Unique Identifier
97082605

Return To Top


MeSH Heading (Major)
Diabetes Mellitus, Insulin-Dependent|*DH/ME/*PP; Dietary Proteins|*AD; Glucose|*ME; Insulin|*SE
MeSH Heading
Adult; Blood Glucose|ME; C-Peptide|ME; Diet Records; Female; Glucagon|ME/PD; Gluconeogenesis; Human; Liver|ME; Male

Publication Type
JOURNAL ARTICLE
ISSN
0021-972X
Country of Publication
UNITED STATES

Record 7 from database: MEDLINE
Return To Top

Title
Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls.
Author
Zillikens MC; van den Berg JW; Wattimena JL; Rietveld T; Swart GR
Address
Department of Internal Medicine II, University Hospital Dijkzigt, Rotterdam, The Netherlands.
Source
J Hepatol, 1993 Mar, 17:3, 377-83
Abstract
Nocturnal glucose administration might prevent gluconeogenesis and concomitant protein loss due to hepatic glycogen depletion. In this study the effects of nocturnal oral glucose supplements on nitrogen metabolism were investigated in 8 cirrhotic patients and in 8 healthy controls. During the night, either polymeric glucose was given or water as placebo. In the patients with cirrhosis on placebo, nitrogen balance was not different from controls: -63 +/- 8 vs. -55 +/- 4 mg N/kg b.wt./9 h (mean +/- SEM). Cirrhotic patients had increased nocturnal protein turnover rates (measured with 15N-glycine) and increased early morning levels of free fatty acids (FFA), lactate, insulin, glucagon and growth hormone. After glucose, nitrogen balance improved by 36% in the cirrhotic group, with a decrease in protein turnover rates and a decrease in plasma levels of beta-hydroxybutyrate, urea and glucagon. In the controls, glucose had no effects on nitrogen balance, on protein turnover or on the hormone levels, except for reduced FFA and ketone body levels. These data show that nocturnal calorie supplements improve nitrogen balance during the night in cirrhotic patients but not in healthy controls. Long interprandial intervals should be avoided in cirrhotic patients.
Language of Publication
English
Unique Identifier
93301428

Return To Top


MeSH Heading (Major)
Glucose|*AD; Liver Cirrhosis|*DT/ME; Liver Glycogen|*ME; Proteins|*ME
MeSH Heading
Administration, Oral; Adult; Aged; Drug Administration Schedule; Female; Human; Male; Middle Age; Nitrogen|ME/UR; Pancreatic Hormones|ME; Polymers; Reference Values; Somatotropin|ME

Publication Type
CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; JOURNAL ARTICLE
ISSN
0168-8278
Country of Publication
IRELAND

Record 8 from database: MEDLINE
Return To Top

Title
Glutamine supplementation of enteral nutrition: impact on whole body protein kinetics and glucose metabolism in critically ill patients.
Author
Long CL; Nelson KM; DiRienzo DB; Weis JK; Stahl RD; Broussard TD; Theus WL; Clark JA; Pinson TW; Geiger JW; et al
Address
Department of Research, Carraway Methodist Medical Center, Birmingham, Alabama 35234, USA.
Source
JPEN J Parenter Enteral Nutr, 1995 Nov, 19:6, 470-6
Abstract
BACKGROUND: Glutamine-supplemented parenteral nutrition has been reported to attenuate the early postoperative reduction in intracellular glutamine and improve protein synthesis and nitrogen balance. We investigated the effect of an enteral formula or protein and glucose kinetics and nitrogen balance in trauma patients. METHODS: The enteral formula (AlitraQ) provided a mean intake of 0.35 g of glutamine/kg body weight per day to 16 trauma patients and was compared with an isonitrogenous formula that provided a mean of 0.05 g of glutamine/kg body weight per day in 14 trauma patients. After 3 days of feeding, protein kinetics were measured using a 4-hour prime-continuous infusion of L-[1-13C]leucine. Glucose kinetics were measured during the same time interval using prime-continuous infusion of [U-14C]- and [6-3H]glucose. RESULTS: Nitrogen balance was not significantly different in the two groups. There were no significant differences in protein turnover, synthesis, and breakdown between the two groups. There were no significant differences in glucose turnover, oxidation, recycling, and percent of VCO2 from glucose oxidation between the two groups. CONCLUSIONS: Glutamine-enriched enteral formulas are well tolerated by the severely injured patient but provide no additional nutritional advantage compared with standard enteral formulas during the first 3 days of feeding immediately after trauma.
Language of Publication
English
Unique Identifier
96357432

Return To Top


MeSH Heading (Major)
Critical Illness|*; Enteral Nutrition|*; Glucose|AD/*ME; Glutamine|*AD; Proteins|*ME
MeSH Heading
Adult; Energy Intake; Female; Human; Kinetics; Male; Methylhistidines|UR; Middle Age; Nitrogen|ME; Oxidation-Reduction; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0148-6071
Country of Publication
UNITED STATES

Record 9 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Effects of epinephrine on human muscle glucose and protein metabolism.
Author
Fryburg DA; Gelfand RA; Jahn LA; Oliveras D; Sherwin RS; Sacca L; Barrett EJ
Address
Department of Internal Medicine, University of Virginia Health Science Center, Charlottesville 22908.
Source
Am J Physiol, 1995 Jan, 268:1 Pt 1, E55-9
Abstract
Systemic epinephrine infusion causes hypoaminoacidemia and inhibits whole body leucine flux (proteolysis) in humans. Its specific action on muscle protein is not known and is difficult to assess during systemic epinephrine infusions, which affect plasma insulin, amino acid, and free fatty acid concentrations. During a steady-state infusion of L-[ring-2,6-3H]phenylalanine, we examined the effect of locally infused epinephrine on the metabolism of protein and glucose in forearm muscle of 10 healthy human volunteers. During local epinephrine infusion, systemic concentrations of glucose, phenylalanine, insulin, and epinephrine were unchanged and lactate declined (P < 0.02). Compared with baseline, epinephrine induced significant increases in forearm blood flow (P < 0.01) and net lactate release (P < 0.001) and a decrease in glucose uptake (P < 0.01) at both 2 and 4 h. At 2 and 4 h phenylalanine release from muscle proteolysis was suppressed (P < 0.01), and at 4 h the net phenylalanine balance was less negative than baseline (P < 0.02), indicating an anticatabolic effect on muscle protein. We conclude that in human forearm muscle epinephrine, at physiological concentrations, has a catabolic effect on muscle glycogen but an anticatabolic action on muscle protein. The mechanism of this latter effect is not known.
Language of Publication
English
Unique Identifier
95142164

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Epinephrine|BL/*PD; Glucose|*ME; Muscle Proteins|*ME; Muscles|*ME
MeSH Heading
Adult; Female; Forearm|BS; Human; Insulin|BL; Lactates|BL/ME; Male; Osmolar Concentration; Phenylalanine|BL/PK; Regional Blood Flow|DE

Publication Type
JOURNAL ARTICLE
ISSN
0002-9513
Country of Publication
UNITED STATES

Record 10 from database: MEDLINE
Order full text for this document

Title
Involvement of phosphoinositide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: implications for glucose metabolism.
Author
Shepherd PR; Nave BT; Rincon J; Haigh RJ; Foulstone E; Proud C; Zierath JR; Siddle K; Wallberg Henriksson H
Address
Department of Biochemistry, University College London, UK.
Source
Diabetologia, 1997 Oct, 40:10, 1172-7
Abstract
Isolated skeletal muscle from healthy individuals was used to evaluate the role of phosphoinositide 3-kinase (PI 3-kinase) in insulin signalling pathways regulating mitogen activated protein kinase (MAP-kinase) and protein kinase-B and to investigate whether MAP-kinase was involved in signalling pathways regulating glucose metabolism. Insulin stimulated glycogen synthase activity (approximately 1.7 fold), increased 3-o-methylglucose transport into human skeletal muscle strips (approximately 2 fold) and stimulated phosphorylation of the p42 ERK-2 isoform of MAP-kinase. This phosphorylation of p42 ERK2 was not blocked by the PI 3-kinase inhibitors LY294002 and wortmannin although it was blocked by the MAP-kinase kinase (MEK) inhibitor PD 98059. However, PD98059 (up to 20 micromol/l) did not block insulin activation of glycogen synthase or stimulation of 3-o-methylglucose transport. Wortmannin and LY294002 did block insulin stimulation of protein kinase-B (PKB) phosphorylation and stimulation of 3-o-methylglucose transport was inhibited by wortmannin (IC50 approximately 100 nmol/l). These results indicate that MAP-kinase is activated by insulin in human skeletal muscle by a PI 3-kinase independent pathway. Furthermore this activation is not necessary for insulin stimulation of glucose transport or activation of glycogen synthase in this tissue.
Language of Publication
English
Unique Identifier
98007754

Order full text for this document


MeSH Heading (Major)
p42 MAP Kinase|AI/AN/*ME; Enzyme Inhibitors|*PD; Glycogen Synthase|AI/*ME; Insulin|*PD; Muscle, Skeletal|DE/*EN/ME/PA; Proto-Oncogene Proteins|AI/*ME; 1-Phosphatidylinositol 3-Kinase|AI/*ME; 3-O-Methylglucose|AI/*ME
MeSH Heading
Adult; Androstadienes|PD; Chromones|PD; Comparative Study; Dose-Response Relationship, Drug; Flavones|PD; Human; Male; Morpholines|PD; Phosphorylation; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0012-186X
Country of Publication
GERMANY


Record 11 from database: MEDLINE
Order full text for this document

Title
Glucose metabolism and protein synthesis in stratified squamous epithelia from young and old mice.
Author
Hill MW; Karthigasan J
Address
Dows Institute for Dental Research, University of Iowa, Iowa City 52242.
Source
Exp Gerontol, 1989, 24:4, 331-40
Abstract
Glucose metabolism in regionally distinct epidermis and oral epithelia of young adult and aged mice was studied using 5-3H glucose and differentially labelled 14C-glucose. The results obtained with 3H-glucose indicate there is active utilization of glucose by all the epithelia examined. However, an enhanced utilization of glucose was observed in old ear epidermis when compared to that in young mice. The measurements of respiratory 14CO2 in the young and old epidermis indicated that aerobic glycolysis was significantly greater in ear epidermis and buccal epithelium from old than from young mice. Pentose phosphate activity was significantly reduced in palate epithelium from old animals when compared with that of young animals. Incorporation of radioactively labelled leucine and histidine revealed some regional differences between the epithelia examined. However, no age-associated differences were observed in any of the tissues. It is concluded that the observed metabolic changes reflect regionally specific adaptations to local factors rather than representing a programmed biological event.
Language of Publication
English
Unique Identifier
90060268

Order full text for this document


MeSH Heading (Major)
Aging|*ME; Epithelium|*ME; Glucose|*ME; Proteins|*BI
MeSH Heading
Animal; Epidermis|ME; Human; Mice; Mice, Inbred C57BL; Mouth Mucosa|ME; Rats; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0531-5565
Country of Publication
ENGLAND


Record 12 from database: MEDLINE
Order full text for this document

Title
Except for alanine, muscle protein catabolism is not influenced by alterations in glucose metabolism during sepsis.
Author
Gore DC; Jahoor F; Hibbert J; DeMaria EJ
Address
Department of Surgery, Medical College of Virginia, Richmond, USA.
Source
Arch Surg, 1995 Nov, 130:11, 1171-6; discussion 1176-7
Abstract
OBJECTIVE: To assess any relationship between hyperglycemia and muscle protein catabolism associated with critical illness. DESIGN: Cohort analytic study. SETTING: Clinical research center and intensive care unit of a university hospital. PARTICIPANTS: Six healthy volunteers and five patients with severe sepsis. INTERVENTIONS: Study subjects were given infusions of 6,6,d2 glucose and 15N lysine for 6 hours. After infusion of the stable isotopes for 2 hours (basal period), dichloroacetate, which accelerates pyruvate oxidation, was given (dichloroacetate period). Leg blood flow was measured by indocyanine green dye dilution, and femoral artery and vein substrate concentrations were quantitated. MAIN OUTCOME MEASURES: The metabolic rates of glucose production, oxidation, and clearance; the whole-body protein breakdown rate; and the net efflux of amino acids from the leg were determined. RESULTS: In comparison with the healthy volunteers, septic patients had significant elevations in glucose production, oxidation, and clearance, accelerated protein catabolism, and greater net peripheral efflux of amino acids. Dichloroacetate significantly decreased glucose production and increased the percentage of glucose directed toward oxidation in both healthy volunteers and septic patients. However, this dichloroacetate-induced perturbation of glucose utilization had no significant effect on whole-body protein breakdown or the efflux of specific amino acids from the leg except for alanine, whose net efflux doubled (P < or = .05). CONCLUSIONS: The findings of this study demonstrate a universal acceleration in the metabolic rates of both intermediary glucose metabolism and protein/amino acid catabolism during sepsis. Except for alanine, however, there appears to be no coupling between these two physiologic responses to sepsis.
Language of Publication
English
Unique Identifier
96050547

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Alanine|*ME; Glucose|*ME; Muscle Proteins|*ME; Sepsis|CO/*ME
MeSH Heading
Adult; Aged; Case-Control Studies; Cohort Studies; Female; Human; Hyperglycemia|CO/ME; Male; Middle Age

Publication Type
JOURNAL ARTICLE
ISSN
0004-0010
Country of Publication
UNITED STATES

Record 13 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Protein and glucose metabolism during isolated closed-head injury.
Author
Flakoll PJ; Wentzel LS; Hyman SA
Address
Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
Source
Am J Physiol, 1995 Oct, 269:4 Pt 1, E636-41
Abstract
Patients with isolated closed-head injuries are characterized by excessive nitrogen loss, hyperglycemia, and increased caloric demand. However, the relative contributions of specific metabolic events such as protein breakdown and synthesis or glucose production and utilization to the physiological changes prevalent during isolated closed-head injury remains unestablished. By use of isotopic dilutions of L-[1-13C]leucine and D-[3-3H]glucose, components of protein and glucose metabolism were examined in patients with isolated closed-head injury (n = 7). Normal overnight-fasted volunteers (n = 8) were also studied as a reference point for comparison. Despite prevailing hyperinsulinemia (29 +/- 5 microU/ml), head-injured patients had elevated plasma leucine concentrations (183 +/- 22 vs. 144 +/- 8 mumol/l), whole body proteolysis (331 +/- 44 vs. 150 +/- 7 mg.kg-1.h-1), protein synthesis (248 +/- 38 vs. 126 +/- 11 mg.kg-1.h-1), and amino acid oxidation (84 +/- 11 vs. 23 +/- 3 mg.kg-1.h-1). Therefore nitrogen loss normally associated with isolated closed-head injury is primarily due to an increase in the rate of whole body proteolysis, with a greater proportion of the resultant amino acids being oxidized for energy. Furthermore, head-injured patients were hyperglycemic (6.7 +/- 0.3 mumol/l) with increased rates of glucose turnover (an estimate of production and utilization) compared with the controls (4.0 +/- 0.7 vs. 2.5 +/- 0.2 mg.kg-1.min-1). Hence, these data suggest that head injury, even in the absence of peripheral trauma, induces a physiological state of accelerated metabolism associated with resistance to insulin action.
Language of Publication
English
Unique Identifier
96043387

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Blood Glucose|*ME; Blood Proteins|*ME; Head Injuries|*BL
MeSH Heading
Adult; Amino Acids|BL; Arteries; Female; Forearm|BS; Hormones|BL; Human; Kinetics; Male; Middle Age; Osmolar Concentration; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0002-9513
Country of Publication
UNITED STATES

Record 14 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
The effect of insulin on glucose and protein metabolism in the forearm of cancer patients.
Author
Newman E; Heslin MJ; Wolf RF; Pisters PW; Brennan MF
Address
Surgical Metabolism Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY 10021.
Source
Surg Oncol, 1992 Aug, 1:4, 257-67
Abstract
This study was designed to study the effect of systemic hyperinsulinaemia (INS) on glucose and protein metabolism in cancer patients. Sixteen cancer patients (8 > 10% weight loss (WL); 8 < 10% weight loss (NWL)) were compared with 12 healthy controls. Glucose uptake (GU) and phenylalanine (PHE) exchange kinetics were measured across the forearm in the postabsorptive state (PA) and in response to INS (71 +/- 5 microU ml-1). At steady state in response to INS, the negative PA PHE net balance became significantly positive, and GU significantly increased, for cancer and control groups, with no significant differences between the two groups. Subset analysis of NWL cancer vs. WL cancer found no difference between WL and NWL for the change in PHE balance from PA and INS, however GU increased significantly only for the NWL group between PA and INS. These data indicate that cancer patients are not resistant to the anabolic effect of INS on protein metabolism, regardless of weight loss, but are resistant to the effect of INS on glucose metabolism when further along in the disease process as evident by more significant weight loss. This differential response to the effect of INS can be exploited in an attempt to promote protein accrual in weight-losing cancer patients.
Language of Publication
English
Unique Identifier
94073456

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Blood Glucose|AN/DE/*ME; Carcinoma, Non-Small-Cell Lung|*BL/DT; Forearm|*PH; Gastrointestinal Neoplasms|*BL/DT; Insulin|*AD; Lung Neoplasms|*BL/DT; Muscle Proteins|*BL/DE
MeSH Heading
Aged; Amino Acids|BL/DE; Comparative Study; Drug Evaluation; Female; Human; Hyperinsulinism|BL; Insulin Resistance; Male; Middle Age; Support, Non-U.S. Gov't; Weight Loss|DE

Publication Type
JOURNAL ARTICLE
ISSN
0960-7404
Country of Publication
ENGLAND

Record 15 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Glucose metabolism, insulin-like growth factor-I, and insulin-like growth factor-binding protein-1 after alcohol withdrawal.
Author
Passilta M; Kervinen K; Kesäniemi YA
Address
Department of Internal Medicine and Biocenter Oulu, University of Oulu, Finland.
Source
Alcohol Clin Exp Res, 1999 Mar, 23:3, 471-5
Abstract
Alcohol abusers often present with deteriorated glucose metabolism and insulin resistance. Changes in other glucoregulators, such as insulin-like growth factor-I (IGF-I) and IGF-binding protein-1 (IGFBP-1) may also be related to alcohol abuse. We studied the effects of alcohol withdrawal on blood glucose, serum insulin and C-peptide, and plasma IGF-I and IGFBP-1 levels in 27 noncirrhotic male alcoholics aged 43 +/- 9.0 (mean +/- SD) years on four consecutive days immediately after withdrawal. A 4-day monitoring period was conducted in four healthy nonalcoholic control men. The groups were similar in age and body mass index. Glucose, insulin, IGF-I, and IGFBP-1 did not differ significantly between the groups at the baseline, but C-peptide was higher in alcoholics (p < 0.01). After alcohol withdrawal, serum insulin and C-peptide levels increased in close correlation with each other (r = 0.82, p < 0.001). During the 4-day observation period in alcoholics, IGFBP-1 levels declined by 59%, whereas IGF-I increased by 41% (p < 0.001 for both comparisons). The change in insulin correlated inversely with the change in IGFBP-1 levels (r = -0.39, p < 0.05). In the control group, glucose, insulin, IGF-I, and IGFBP-1 remained unchanged during the 4-day monitoring period, whereas some reduction was observed in C-peptide. In conclusion, alcohol withdrawal enhances insulin production, as seen in increased C-peptide levels. An inverse correlation between the changes in insulin and that in IGFBP-1 might suggest that inhibition of IGFBP-1 by insulin remains largely unchanged during the acute phase of alcohol withdrawal.
Language of Publication
English
Unique Identifier
99210195

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Blood Glucose|*ME; Ethanol|*AE; Insulin-Like Growth Factor I|*ME; Insulin-Like Growth-Factor Binding Protein 1|*ME; Substance Withdrawal Syndrome|BL/*ME
MeSH Heading
Adult; Body Mass Index; C-Peptide|BL; Human; Insulin|BL; Male; Middle Age; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0145-6008
Country of Publication
UNITED STATES

Record 16 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma.
Author
Battezzati A; Terruzzi I; Perseghin G; Bianchi E; Di Carlo V; Pozza G; Luzi L
Address
Division of Endocrinology-Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Source
Diabetes, 1995 Jul, 44:7, 837-44
Abstract
The ability of chronic endogenous hyperinsulinemia to induce a resistance to insulin action on protein and glucose metabolism was studied in 10 subjects affected by a benign (functioning) insulinoma and 18 healthy subjects by means of infusions of [1-(14)C]leucine and [3-(3)H] glucose. The insulinoma subjects were divided into two groups with moderate (139 +/- 12 pmol/l) (n = 5) and marked (438 +/- 42 pmol/l) (n = 5) hyperinsulinemia and were studied during a euglycemic dextrose infusion. Control subjects were studied postabsorptively and during a low-dose (0.3 mU.kg-1.min-1) (n = 3) and a high-dose (1 mU.kg-1.min-1) (n = 15) euglycemic insulin clamp to match peripheral insulin concentrations with those of insulinoma subjects. In insulinoma subjects there was no correlation among plasma insulin concentration and leucine concentration (r = 0.05), endogenous leucine flux (r = 0.44), hepatic glucose production (r = 0.47), and glucose uptake (r = 0.05). Insulinoma subjects with marked hyperinsulinemia demonstrated a defective suppression of leucine concentrations (100 +/- 11 vs. 65 +/- 5 mumol/l, P < 0.01), endogenous leucine flux (50.1 +/- 6.3 vs. 27.1 +/- 0.9 mumol.m-2.min-1, P < 0.01), and hepatic glucose production (5.4 +/- 2.0 vs. 0.6 +/- 0.6 mumol.kg-1.min-1, P < 0.05), and a defective stimulation of glucose uptake (13.5 +/- 1.6 vs. 41.1 +/- 2.8 mumol.kg-1.min-1, P < 0.001) with respect to normal subjects at a comparable degree of hyperinsulinemia.(ABSTRACT TRUNCATED AT 250 WORDS)
Language of Publication
English
Unique Identifier
95309554

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Blood Glucose|DE/*ME; Glucose|*ME; Hyperinsulinism|BL/*ME; Insulin|BL/*PD; Insulinoma|BL/*ME; Pancreatic Neoplasms|BL/*ME; Proteins|*ME
MeSH Heading
Adult; Carbon Radioisotopes; Chronic Disease; Comparative Study; Glucose Clamp Technique; Human; Keto Acids|ME; Leucine|ME; Liver|ME; Middle Age; Radioisotope Dilution Technique; Reference Values; Support, Non-U.S. Gov't; Tritium

Publication Type
JOURNAL ARTICLE
ISSN
0012-1797
Country of Publication
UNITED STATES

Record 17 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle.
Author
Louard RJ; Fryburg DA; Gelfand RA; Barrett EJ
Address
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06510.
Source
J Clin Invest, 1992 Dec, 90:6, 2348-54
Abstract
Physiologic increases of insulin promote net amino acid uptake and protein anabolism in forearm skeletal muscle by restraining protein degradation. The sensitivity of this process to insulin is not known. Using the forearm perfusion method, we infused insulin locally in the brachial artery at rates of 0.00 (saline control), 0.01, 0.02, 0.035, or 0.05 mU/min per kg for 150 min to increase local forearm plasma insulin concentration by 0, approximately 20, approximately 35, approximately 60, and approximately 120 microU/ml (n = 35). L-[ring-2,6-3H]phenylalanine and L-[1-14C]leucine were infused systemically, and the net forearm balance, rate of appearance (Ra) and rate of disposal (R(d)) of phenylalanine and leucine, and forearm glucose balance were measured basally and in response to insulin infusion. Compared to saline, increasing rates of insulin infusion progressively increased net forearm glucose uptake from 0.9 mumol/min per 100 ml (saline) to 1.0, 1.8, 2.4, and 4.7 mumol/min per 100 ml forearm, respectively. Net forearm balance for phenylalanine and leucine was significantly less negative than basal (P < 0.01 for each) in response to the lowest dose insulin infusion, 0.01 mU/min per kg, and all higher rates of insulin infusion. Phenylalanine and leucine R(a) declined by approximately 38 and 40% with the lowest dose insulin infusion. Higher doses of insulin produced no greater effect (decline in R(a) varied between 26 and 42% for phenylalanine and 30-50% for leucine). In contrast, R(d) for phenylalanine and leucine did not change with insulin. We conclude that even modest increases of plasma insulin can markedly suppress proteolysis, measured by phenylalanine R(a), in human forearm skeletal muscle. Further increments of insulin within the physiologic range augment glucose uptake but have little additional effect on phenylalanine R(a) or balance. These results suggest that proteolysis in human skeletal muscle is more sensitive than glucose uptake to physiologic increments in insulin.
Language of Publication
English
Unique Identifier
93107318

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Glucose|*ME; Insulin|*PD; Muscle Proteins|*ME; Muscles|*ME
MeSH Heading
Adult; Amino Acids|ME; Arm; Female; Human; Leucine|ME; Male; Phenylalanine|ME; Regional Blood Flow

Publication Type
JOURNAL ARTICLE
ISSN
0021-9738
Country of Publication
UNITED STATES

Record 18 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Protein-metabolism kinetics and energy-substrate utilization in infants fed parenteral solutions with different glucose-fat ratios [see comments]
Author
Bresson JL; Bader B; Rocchiccioli F; Mariotti A; Ricour C; Sachs C; Rey J
Address
DÆepartement de PÆediatrie, HÈopital des Enfants Malades, Paris, France.
Source
Am J Clin Nutr, 1991 Aug, 54:2, 370-6
Abstract
The relative effect of glucose and lipids on whole-body protein-metabolism kinetics was assessed in seven infants undergoing parenteral feeding. Protein intake was kept constant and nonprotein energy was either provided as glucose alone or as an isoenergetic glucose-lipid mixture according to a randomized crossover trial. Protein metabolism and energy-substrate utilization were assessed by a primed, constant L-[13C]leucine infusion, combined with indirect calorimetry. There was a significant difference in the pattern of energy-substrate utilization according to regime. Protein turnover (11.3 +/- 0.7 vs 9.8 +/- 0.4 g.kg-1.d-1; P less than 0.05), protein breakdown (8.4 +/- 0.6 vs 7.1 +/- 0.4 g.kg-1.d-1; P less than 0.05), and amino acid oxidation rates (2.7 +/- 0.4 vs 1.4 +/- 0.5 g.kg-1.d-1; P less than 0.05) were higher for the glucose than the glucose-lipid treatment, whereas protein-synthesis rates did not significantly differ. These results suggest that the nature of energy substrates delivered to parenterally fed infants may affect protein metabolism.
Language of Publication
English
Unique Identifier
91314492

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Energy Metabolism|*; Glucose|*AD; Lipids|*AD; Parenteral Nutrition|*; Proteins|*ME
MeSH Heading
Calorimetry, Indirect; Fatty Acids, Nonesterified|BL; Human; Infant; Infant, Newborn; Keto Acids|BL; Kinetics; Leucine|BL; Support, Non-U.S. Gov't

Publication Type
CLINICAL TRIAL; JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
ISSN
0002-9165
Country of Publication
UNITED STATES

Record 19 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Effects of dietary protein restriction on glucose and insulin metabolism in normal and diabetic humans.
Author
Larivière F; Chiasson JL; Schiffrin A; Taveroff A; Hoffer LJ
Address
McGill Nutrition and Food Science Centre, McGill University, Montreal, Quebec, Canada.
Source
Metabolism, 1994 Apr, 43:4, 462-7
Abstract
We determined whether the amount of protein in the diet can affect insulin requirements in subjects with diabetes mellitus and glucose metabolism in normal subjects. Seven normal-weight volunteers with uncomplicated, intensively controlled, type I (insulin-dependent) diabetes and 12 similar nondiabetic subjects were studied on a metabolic ward before and after consuming a maintenance-energy but protein-free diet for 10 days. Blood glucose levels of diabetic subjects were measured seven times daily in response to insulin administration by continuous subcutaneous infusion. The plasma glucose appearance rate (Ra) was measured in seven normal subjects and all diabetic subjects using a primed-continuous infusion of D-[6,6-2H2]glucose. After adaptation to the protein-restricted diet, diabetic subjects experienced a 30% decrease in average preprandial and average daily blood glucose concentrations (P < .01); this occurred despite a concurrent 25% decrease in both basal and bolus insulin dosages (P < .001). Protein restriction decreased the postabsorptive glucose Ra (P < .05) and insulin concentrations (P < .01) of normal subjects by 20%, and increased their fasting glucagon concentrations by 24% (P < .01). We conclude that severe protein restriction decreases insulin requirements in type I diabetes and fasting hepatic glucose output and basal insulin levels in normal subjects. This effect appears to be mediated in part by decreased hepatic gluconeogenesis, but a contributory influence of increased insulin sensitivity is not ruled out.
Language of Publication
English
Unique Identifier
94211139

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Blood Glucose|*ME; Diabetes Mellitus, Insulin-Dependent|*BL; Dietary Proteins|AD/*PD; Insulin|*BL
MeSH Heading
Adult; Human; Male; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0026-0495
Country of Publication
UNITED STATES

Record 20 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
Protein: metabolism and effect on blood glucose levels.
Author
Franz MJ
Address
International Diabetes Center, Minneapolis, Minnesota 55416, USA.
Source
Diabetes Educ, 1997 Nov, 23:6, 643-6, 648, 650-1
Abstract
Insulin is required for carbohydrate, fat, and protein to be metabolized. With respect to carbohydrate from a clinical standpoint, the major determinate of the glycemic response is the total amount of carbohydrate ingested rather than the source of the carbohydrate. This fact is the basic principle of carbohydrate counting for meal planning. Fat has little, if any, effect on blood glucose levels, although a high fat intake does appear to contribute to insulin resistance. Protein has a minimal effect on blood glucose levels with adequate insulin. However, with insulin deficiency, gluconeogenesis proceeds rapidly and contributes to an elevated blood glucose level. With adequate insulin, the blood glucose response in persons with diabetes would be expected to be similar to the blood glucose response in persons without diabetes. The reason why protein does not increase blood glucose levels is unclear. Several possibilities might explain the response: a slow conversion of protein to glucose, less protein being converted to glucose and released than previously thought, glucose from protein being incorporated into hepatic glycogen stores but not increasing the rate of hepatic glucose release, or because the process of gluconeogenesis from protein occurs over a period of hours and glucose can be disposed of if presented for utilization slowly and evenly over a long time period.
Language of Publication
English
Unique Identifier
98077929

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Blood Glucose|*ME; Diabetes Mellitus, Insulin-Dependent|*ME; Diabetes Mellitus, Non-Insulin-Dependent|*ME; Dietary Proteins|*ME/PD
MeSH Heading
Dietary Carbohydrates|ME; Dietary Fats|ME; Human

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0145-7217
Country of Publication
UNITED STATES

Record 21 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
The effect of a low protein diet with amino acid/keto acid supplements on glucose metabolism in children with uremia.
Author
Mak RH; Turner C; Thompson T; Haycock G; Chantler C
Address
 
Source
J Clin Endocrinol Metab, 1986 Oct, 63:4, 985-9
Abstract
Six children with chronic renal failure were treated with dietary protein restriction and essential amino acid and keto acid supplements for 6 months. Dietary protein and phosphate intake decreased, dietary calcium increased, and dietary carbohydrate and energy did not change. Plasma urea and urea to creatinine ratio decreased significantly during treatment. Glucose metabolism was studied before and after 6 months of treatment using the hyperglycemic clamp technique. Fasting hyperglycemia, glucose intolerance, and insulin resistance improved during treatment, while fasting insulin and insulin levels during hyperglycemia did not change. These metabolic changes were not related to hyperparathyroidism and were probably due to reduction in nitrogen toxicity.
Language of Publication
English
Unique Identifier
86304859

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Amino Acids, Essential|*AD; Dietary Proteins|*AD; Glucose|*ME; Keto Acids|*AD; Uremia|*DH/ME
MeSH Heading
Adolescence; Child; Female; Human; Male; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0021-972X
Country of Publication
UNITED STATES

Record 22 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
Testosterone treatment in adolescents with delayed puberty: changes in body composition, protein, fat, and glucose metabolism.
Author
Arslanian S; Suprasongsin C
Address
Division of Pediatric Endocrinology, Metabolism and Diabetes Mellitus, Children's Hospital, University of Pittsburgh, Pennsylvania 15213, USA. arslans@chplink.chp.edu
Source
J Clin Endocrinol Metab, 1997 Oct, 82:10, 3213-20
Abstract
Previously, we demonstrated decreased protein breakdown and insulin resistance in pubertal adolescents compared with prepubertal children. Puberty-related increases in sex steroids and/or GH could be potentially responsible. In the present study, the effects of 4 months of testosterone enanthate (50 mg in every 2 weeks) on body composition, protein, fat, and glucose metabolism and insulin sensitivity were evaluated in adolescents with delayed puberty. Body composition was assessed by H218O-dilution principle. Protein breakdown, oxidation, and synthesis were measured during primed constant infusion of [1-13C]leucine. Whole-body lipolysis was measured during primed constant infusion of [2H5]glycerol. Insulin action in suppressing proteolysis and lipolysis and stimulating glucose disposal was assessed during a stepwise hyperinsulinemic (10 and 40 mU-m2.min) euglycemic clamp. Fat and glucose oxidation rates were calculated from indirect calorimetry measurements. After 4 months of testosterone treatment, height, weight, and fat free mass (FFM) increased and fat mass, percent body fat, plasma cholesterol, high- and low-density lipoproteins, and leptin levels decreased significantly. Whole-body proteolysis and protein oxidation were lower after testosterone treatment (proteolysis, 0.49 +/- 0.03 vs 0.54 +/- 0.04 g.h.kg FFM, P = 0.032; oxidation, 0.05 +/- 0.01 vs. 0.09 +/- 0.01 g.h.kg FFM, P = 0.015). Protein synthesis was not different, and resting energy expenditure was not different. Total body lipolysis was not affected by testosterone treatment, however, fat oxidation was higher after testosterone (pre-: 2.4 +/- 0.7 vs. post-: 3.5 +/- 0.7 mumol.kg.min, P = 0.031). During the 40 mU.m2.min hyperinsulinemia, insulin sensitivity of glucose metabolism was not affected with testosterone therapy (59.1 +/- 8.8 vs. 57.1 +/- 8.2 mumol.kg.min per muU/mL). However, metabolic clearance rate of insulin was higher posttestosterone (13.6 +/- 1.1 vs. 16.7 +/- 0.8 mL.kg.min, P = 0.004). In conclusion, after 4 months of low-dose testosterone treatment in adolescents with delayed puberty 1) FFM increases and fat mass and leptin levels decrease; 2) postabsorptive proteolysis and protein oxidation decrease; 3) fat oxidation increases; and 4) insulin sensitivity in glucose metabolism does not change, whereas insulin clearance increases. These longitudinal observations are in agreement with our previous cross-sectional studies of puberty and demonstrate sparing of protein breakdown of approximately 1.2 g.kg.day FFM, wasting of fat mass, but no change in insulin sensitivity after short periods of low-dose testosterone supplementation.
Language of Publication
English
Unique Identifier
97469924

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Body Composition|*DE; Puberty, Delayed|*DT/*ME/PA; Testosterone|*TU
MeSH Heading
Adolescence; Fats|ME; Glucose|ME; Human; Hyperinsulinism|ME; Longitudinal Studies; Male; Oxidation-Reduction|DE; Proteins|ME; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.

Publication Type
CLINICAL TRIAL; JOURNAL ARTICLE
ISSN
0021-972X
Country of Publication
UNITED STATES

Record 23 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
Dissociation of the effects of epinephrine and insulin on glucose and protein metabolism.
Author
Castellino P; Luzi L; Del Prato S; DeFronzo RA
Address
Diabetes Division, University of Texas Health Science Center, San Antonio 78284.
Source
Am J Physiol, 1990 Jan, 258:1 Pt 1, E117-25
Abstract
The separate and combined effects of insulin and epinephrine on leucine metabolism were examined in healthy young volunteers. Subjects participated in four experimental protocols: 1) euglycemic insulin clamp (+80 microU/ml), 2) epinephrine infusion (50 ng.kg-1.min-1) plus somatostatin with basal replacement of insulin and glucagon, 3) combined epinephrine (50 ng.kg-1.min-1) plus insulin (+80 microU/ml) infusion, and 4) epinephrine and somatostatin as in study 2 plus basal amino acid replacement. Studies were performed with a prime-continuous infusion of [1-14C]leucine and indirect calorimetry. Our results indicate that 1) hyperinsulinemia causes a generalized decrease in plasma amino acid concentrations, including leucine; 2) the reduction in plasma leucine concentration is primarily due to an inhibition of endogenous leucine flux; nonoxidative leucine disposal decreases after insulin infusion; 3) epinephrine, without change in plasma insulin concentration, reduces plasma amino acid levels; 4) combined epinephrine-insulin infusion causes a greater decrease in plasma amino levels than observed with either hormone alone; this is because of a greater inhibition of endogenous leucine flux; and 5) when basal amino acid concentrations are maintained constant with a balanced amino acid infusion, epinephrine inhibits the endogenous leucine flux. In conclusion, the present results do not provide support for the concept that epinephrine is a catabolic hormone with respect to amino acid-protein metabolism. In contrast, epinephrine markedly inhibits insulin-mediated glucose metabolism.
Language of Publication
English
Unique Identifier
90145070

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Blood Glucose|*ME; Epinephrine|AD/BL/*PD; Insulin|BL/*PD; Leucine|BL/*ME; Proteins|*ME
MeSH Heading
Adult; Amino Acids|BL; Bicarbonates|ME; C-Peptide|BL; Carbon Dioxide|AN; Carbon Radioisotopes; Glucagon|BL; Glucose Clamp Technique; Human; Infusions, Intravenous; Insulin Infusion Systems; Oxidation-Reduction; Radioisotope Dilution Technique; Respiration; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0002-9513
Country of Publication
UNITED STATES

Record 24 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
Interrelationships of glucose and protein metabolism in obese adolescents during short-term hypocaloric dietary therapy.
Author
Dietz WH Jr; Wolfe RR
Address
 
Source
Am J Clin Nutr, 1985 Sep, 42:3, 380-90
Abstract
We studied the interrelationship of nitrogen balance (N-bal) and rates of glucose appearance (Ra), determined isotopically using U-13C-glucose, in 14 obese adolescents consuming either (1.5 g protein and 1.0 g glucose)/kg ideal body weight/day or an isonitrogenous diet made isocaloric with fat. Nitrogen balance was significantly (p less than .01) more positive with added glucose. Changes in plasma insulin, free fatty acids, or beta-hydroxybutyrate did not reliably predict N-bal. The Ra of glucose decreased significantly on both diets, but was significantly lower (p less than .001) after the addition of fat. A significant correlation of N-bal with Ra (r = 0.70, p less than .01) was observed only in the absence of dietary glucose. Insulin levels correlated with N-bal only in the presence of dietary glucose (r = 0.72, p less than .01). Nitrogen balance in the absence of dietary carbohydrate may be a consequence of net peripheral protein catabolism that is not directly mediated by the need for gluconeogenic precursors.
Language of Publication
English
Unique Identifier
85303960

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Diet, Reducing|*; Glucose|AD/*ME; Obesity|*ME; Proteins|*ME
MeSH Heading
Adolescence; Body Weight; Child; Dietary Fats|AD; Dietary Proteins|AD; Female; Human; Insulin|BL; Male; Mathematics; Nitrogen|ME; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Time Factors

Publication Type
JOURNAL ARTICLE
ISSN
0002-9165
Country of Publication
UNITED STATES

Record 25 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Effect of glucose supplement timing on protein metabolism after resistance training.
Author
Roy BD; Tarnopolsky MA; MacDougall JD; Fowles J; Yarasheski KE
Address
Department of Kinesiology, McMaster University, Hamilton, Ontario, Canada.
Source
J Appl Physiol, 1997 Jun, 82:6, 1882-8
Abstract
We determined the effect of the timing of glucose supplementation on fractional muscle protein synthetic rate (FSR), urinary urea excretion, and whole body and myofibrillar protein degradation after resistance exercise. Eight healthy men performed unilateral knee extensor exercise (8 sets/approximately 10 repetitions/approximately 85% of 1 single maximal repetition). They received a carbohydrate (CHO) supplement (1 g/kg) or placebo (Pl) immediately (t = 0 h) and 1 h (t = +1 h) postexercise. FSR was determined for exercised (Ex) and control (Con) limbs by incremental L-[1-13C]leucine enrichment into the vastus lateralis over approximately 10 h postexercise. Insulin was greater (P < 0.01) at 0.5, 0.75, 1.25, 1.5, 1.75, and 2 h, and glucose was greater (P < 0.05) at 0.5 and 0.75 h for CHO compared with Pl condition. FSR was 36.1% greater in the CHO/Ex leg than in the CHO/Con leg (P = not significant) and 6.3% greater in the Pl/Ex leg than in the Pl/Con leg (P = not significant). 3-Methylhistidine excretion was lower in the CHO (110.43 +/- 3.62 mumol/g creatinine) than P1 condition (120.14 +/- 5.82, P < 0.05) as was urinary urea nitrogen (8.60 +/- 0.66 vs. 12.28 +/- 1.84 g/g creatinine, P < 0.05). This suggests that CHO supplementation (1 g/kg) immediately and 1 h after resistance exercise can decrease myofibrillar protein breakdown and urinary urea excretion, resulting in a more positive body protein balance.
Language of Publication
English
Unique Identifier
97350078

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Glucose|*AD/PD; Muscle Proteins|*ME; Physical Fitness|*
MeSH Heading
Adult; Blood Glucose|AN; Creatinine|UR; Human; Keto Acids|BL; Male; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Time Factors

Publication Type
CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; JOURNAL ARTICLE
ISSN
8750-7587
Country of Publication
UNITED STATES

Record 26 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls.
Author
Zillikens MC; van den Berg JW; Wattimena JL; Rietveld T; Swart GR
Address
Department of Internal Medicine II, University Hospital Dijkzigt, Rotterdam, The Netherlands.
Source
J Hepatol, 1993 Mar, 17:3, 377-83
Abstract
Nocturnal glucose administration might prevent gluconeogenesis and concomitant protein loss due to hepatic glycogen depletion. In this study the effects of nocturnal oral glucose supplements on nitrogen metabolism were investigated in 8 cirrhotic patients and in 8 healthy controls. During the night, either polymeric glucose was given or water as placebo. In the patients with cirrhosis on placebo, nitrogen balance was not different from controls: -63 +/- 8 vs. -55 +/- 4 mg N/kg b.wt./9 h (mean +/- SEM). Cirrhotic patients had increased nocturnal protein turnover rates (measured with 15N-glycine) and increased early morning levels of free fatty acids (FFA), lactate, insulin, glucagon and growth hormone. After glucose, nitrogen balance improved by 36% in the cirrhotic group, with a decrease in protein turnover rates and a decrease in plasma levels of beta-hydroxybutyrate, urea and glucagon. In the controls, glucose had no effects on nitrogen balance, on protein turnover or on the hormone levels, except for reduced FFA and ketone body levels. These data show that nocturnal calorie supplements improve nitrogen balance during the night in cirrhotic patients but not in healthy controls. Long interprandial intervals should be avoided in cirrhotic patients.
Language of Publication
English
Unique Identifier
93301428

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Glucose|*AD; Liver Cirrhosis|*DT/ME; Liver Glycogen|*ME; Proteins|*ME
MeSH Heading
Administration, Oral; Adult; Aged; Drug Administration Schedule; Female; Human; Male; Middle Age; Nitrogen|ME/UR; Pancreatic Hormones|ME; Polymers; Reference Values; Somatotropin|ME

Publication Type
CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; JOURNAL ARTICLE
ISSN
0168-8278
Country of Publication
IRELAND

Record 27 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Low protein diet in uremia: effects on glucose metabolism and energy production rate.
Author
Rigalleau V; Combe C; Blanchetier V; Aubertin J; Aparicio M; Gin H
Address
Clinique MÆedicale and Service de NÆephrologie, HÈopital Pellegrin-Tripode, Bordeaux, France.
Source
Kidney Int, 1997 Apr, 51:4, 1222-7
Abstract
Low-protein diets (LPD) increase insulin-mediated glucose disposal in chronic renal failure (CRF), but the fate of the better utilized glucose and the effect on energy production rate are unknown. Using a two-step (1 and 5 mU x kg(-1) x min(-1)) euglycemic hyperinsulinemic clamp combined with indirect calorimetry, we studied the effects of a LPD (0.3 g x kg(-1) x day(-1), supplemented with essential amino acids and ketoanalogs) in six patients suffering from chronic renal failure. After three months of diet, no significant change was observed concerning glomerular filtration rate, body wt, or arterial pH. In the postabsorptive state, plasma glucose and insulin levels were significantly lower, and energy production rose from 15.72 +/- 0.48 to 17.16 +/- 0.67 Cal x kg(-1) x min(-1) (P < 0.05). Insulin-stimulated glucose oxidation (2.36 +/- 0.29 vs. 3.37 +/- 0.35 mg x kg(-1) x min(-1); P < 0.05 at first clamp step) and nonoxidative disposal (P < 0.05 at both clamp steps) increased after LPD. This confirms that LPD ameliorates insulin sensitivity in CRF, even for low plasma insulin concentrations. Since energy production rate is increased by LPD, the caloric intake should be increased when protein intake is restricted.
Language of Publication
English
Unique Identifier
97236594

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Diet, Protein-Restricted|*; Glucose|*ME; Uremia|*DH/*ME
MeSH Heading
Adult; Energy Intake; Energy Metabolism; Female; Glucose Clamp Technique; Human; Insulin|AD/ME; Insulin Resistance|PH; Kidney Failure, Chronic|DH/ME; Male; Middle Age; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0085-2538
Country of Publication
UNITED STATES

Information on HealthGate.com is not a substitute for professional medical care or advice but should be used only as an aid in understanding current medical knowledge. A physician should always be consulted for any health problem or medical condition.

 We subscribe to the HONcode principles
of the Health On the Net Foundation
Send comments to support@healthgate.com
Copyright © 2000 HealthGate® Data Corp. All rights reserved.

Home Page -- Karl Loren Web Site Navigation Bar
Karl Loren Diet Cancer & Biopsies Oral Chelation High Cholesterol Risk Factor
Karl Loren's Personal
Diet Diary
Ultrasound Technology Karl Loren Personal Plaque Isn't Where They Say It Is
Aajonus Vonderplanitz Arthritis Karl's Adventure
 With The IRS
Bones Are Alive
Diabetes Table Of Contents Jean Ross Witch Doctors & Ethnobotany
Sugar Shopping Cart Order Karl Loren's Book
On Heart Disease
AIDS
Raw Milk Search  This Web Write To Karl Loren Right To Die
Why You Should Drink More Water Transfer Factor & The Immune System What Is A Free Radical? Methyl Sulfonyl Methane
Taheebo Tea Germanium Corruption In The American Heart Association James Coburn's Use Of MSM To Handle Arthritis
Floaters Rather Than Sinkers Toxic Metals Heart Disease Jimmy Keller -- Forbidden Medicine
The Links Below Jump To Pages On Whatever Web You Are In
Table Of Contents Search This Web Navigation Help Page
Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally.  Click here or on his name in the box below.
The Links Below Are To Various Web Sites Published By Karl Loren
Karl Loren Web Vibrant Life Web Karl Loren's Book
Super Colostrum Bulk MSM Heart Disease
Emmessar Happiness Arthritis
Instead Of Chelation Therapy Super Colostrum (2)
Karl Loren's Catalog Store Central Page For All 12 Webs!
 

I promise to answer your message -- click here to send me a personal message

Dear Karl,                                        

 

 

 

 

 


SUBSCRIBE:  The Vibrant Life Magazine is a free electronic weekly newsletter written and published by Vibrant life.  You can view more than 50 back issues of this publication by clicking here.  The newsletter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.  The letter has been changed to product and information news which is sent out regularly each week.

E-Mail Address:
First Name:
Last Name:

REMOVAL:  You can remove yourself from the subscription list in several different ways.  Click here to read about this entire newsletter system.  Every edition of Product and Information Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.  If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.  Thus, no one else can unsubscribe you, from some other computer, without your knowledge.  But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.

E-Mail Address:

Personal Message:  When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.  Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.  You can select particular information you would like to receive, along with the free cassette tape and catalog.

[FrontPage Save Results Component]

Please provide the following contact information:

First name required
Last name required
Middle initial
Information
Request
 

 

Title
Organization
Work Phone
Home Phone
FAX
E-mail required
URL
Address 1 requested
Address 2
City requested
State/Province requested
Zip Code requested
Countryrequested

How Did You Find This Web Site?

Select one

 

What do you think of this site or ... ?  I promise to answer your comments, personally.



Click here to add the Wednesday Letter as a Channel on your desktop.   If your browser is so-equipped, you will be guided through a series of simple questions (about subscription information).  Depending on your choices you can show the Vibrant Life Wednesday Letter as one of your "active channels" which will automatically download the new Wednesday Letter every month.  In this way you can have the Wednesday Letter delivered to your desktop during the night (or your schedule) for immediate viewing in your browser.  You can turn on or off this channel, at will, and delete the channel from your desktop at any time.  With this feature operating you can click on the Wednesday Letter channel at any time to read the most recent copy of this electronic letter.


You can reach Vibrant Life in many ways, including by mail to Vibrant Life, PO Box 10666, Burbank, CA 91510-0666.  Within the US and Canada, use the toll free number:  (800) 523-4521, the local number:  (818) 558-7099, eMail to barb@oralchelation.com or any one of the hundreds of message forms throughout the 60 web sites.  Vibrant Life normally ships the same day we get an order.  There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.  Check out our companion site, at:  http://www.oralchelation.net where Karl's 2000 page book is published.  Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION.  His personal philosophical articles are at PHILOSOPHY

Copyright © May 23, 2012 4:47 PM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.  Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:  One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site.  This permission does not extend to materials on this site which are copyrighted by others.